BCG Immunotherapy-Induced Extracellular Vesicles in Bladder Cancer

Carlos J. Ortiz-Bonilla published a research article on figshare in April 2026. The 395.2 KB PDF describes a study investigating the role of Bacillus Calmette-Guérin (BCG)-induced extracellular vesicles (EVs) in promoting antitumor immunity in bladder cancer. The work includes in vitro experiments with cell lines and co-culture systems, and in vivo testing using a murine tumor model.

Use Cases

• Study the immunomodulatory protein cargo of BCG-induced EVs based on the description of MHC and co-stimulatory molecule enrichment.
• Investigate dendritic cell activation pathways based on the described functional assays.
• Model the enhancement of T cell activity in vitro based on the co-culture system results.
• Assess the predictive biomarker potential of EVs for BCG therapy efficacy based on the conclusions.
• Explore the immune cascade triggered by BCG internalization in bladder cancer cells based on the described mechanism.

Strengths

• Data is openly licensed under CC-BY-4.0.
• The research includes both in vitro and in vivo validation components as described.
• The dataset is recent, last updated on 2026-04 13.

Limitations

• The dataset is a single 395.2 KB PDF file, which is a very small and limited data scope.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Collection Method

Research employing bladder cancer cell lines, dendritic and T cell co-cultures, nanoparticle tracking analysis, molecular profiling, Western blotting, and murine tumor models.

Time Range

Study period not specified.

Freshness

Last updated 2026-04-13 05:46:21.

Geography

Geographic scope of the research not specified.